What is NDC 33342-149?

33342-149 is the product NDC for solifenacin succinate, Solifenacin succinate 10 mg/1 tablet, coated, listed with the FDA by Macleods Pharmaceuticals Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for solifenacin succinate?

50 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

solifenacin succinate NDC 33342-149

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-149Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0149Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
33342-149-07	3334201490733342014907	30 TABLET, COATED in 1 CONTAINER (33342-149-07)Marketed from Feb 20, 2024
33342-149-10	3334201491033342014910	90 TABLET, COATED in 1 CONTAINER (33342-149-10)Marketed from Feb 20, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): solifenacin succinate
Generic name (nonproprietary): solifenacin succinate
Active ingredients: Solifenacin succinate — 10 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Macleods Pharmaceuticals LimitedNDC labeler code 33342
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204374
Marketing start: Feb 20, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 33342-149_0cadbdf8-3fce-49c8-a227-ad6b750e7b71SPL ID 0cadbdf8-3fce-49c8-a227-ad6b750e7b71
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342014907 followed by a unit qualifier and the quantity

Package 33342-0149-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 33342-149

What is NDC 33342-149?: 33342-149 is the product NDC for solifenacin succinate, Solifenacin succinate 10 mg/1 tablet, coated, listed with the FDA by Macleods Pharmaceuticals Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: solifenacin succinate.
What is the active ingredient?: Solifenacin succinate.
Who is the labeler?: Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for solifenacin succinate?: 50 other product NDCs are listed under this name. See all solifenacin succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other solifenacin succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Solifenacin succinate	Solifenacin succinate 5 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0831	72303-0831-0172303-0831-02
Solifenacin succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0832	72303-0832-0172303-0832-02
solifenacin succinate	Solifenacin succinate 5 mg/1	Tablet, CoatedOral	Macleods Pharmaceuticals Limited	33342-148	33342-0148-0733342-0148-10
Solifenacin Succinate	Solifenacin succinate 5 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-878	65862-0878-0365862-0878-3065862-0878-90+1 more
Solifenacin Succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-879	65862-0879-0365862-0879-3065862-0879-90+1 more
solifenacin succinate	Solifenacin succinate 5 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-027	31722-0027-3031722-0027-3131722-0027-90
solifenacin succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-028	31722-0028-3031722-0028-3131722-0028-90
Solifenacin Succinatesolifenacin succiate	Solifenacin succinate 5 mg/1	Tablet, Film coatedOral	AvKARE	42291-739	42291-0739-3042291-0739-90
Solifenacin Succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	AvKARE	42291-740	42291-0740-3042291-0740-90
Solifenacin succinate	Solifenacin succinate 5 mg/1	Tablet, Film coatedOral	Actavis Pharma, Inc.	0591-3795	00591-3795-1900591-3795-30

All 51 solifenacin succinate NDCs

Other NDCs under ANDA 204374

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204374
Product	Strength	Form · route	Labeler	Product NDC
solifenacin succinate	Solifenacin succinate 5 mg/1	Tablet, CoatedOral	Macleods Pharmaceuticals Limited	33342-148